RecruitingNCT04330521
Impact of the Coronavirus (COVID-19) on Patients With Cancer
Sponsor
Stanford University
Enrollment
50 participants
Start Date
Apr 8, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to understand the impact of COVID-19 on patients with cancer through a survey.
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- The patients must be 18 years or older.
- Patients who opt in to complete the survey.
- Patients must have the capacity to verbally consent for the interview.
Exclusion Criteria1
- Patients who under the age of 18 years old.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04330521
Related Trials
Small Bowel Capsule Endoscopy in Lynch Syndrome
NCT074726861 location
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)
NCT043337063 locations
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
NCT068355699 locations
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
NCT0653305951 locations
Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder
NCT070727283 locations